Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Mesothelioma: HELP
Marcello Deraco
Based on 30 articles published since 2008
||||
Expertise Level
The expertise of Marcello Deraco ranks in the
  • Top 0.36%
  • ... of 15,704 published authors worldwide on Mesothelioma
  • ... from 2008 through 2018
  • ... based on contributions to 30 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Deraco, M   ·   Deraco, Marcello
Work Locations
Details
Most likely:    National Cancer Institute Milan      
2018
  • Peritoneal Surface Malignancies Unit, Colon and Rectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Surgery A, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Israel. · Peritoneal Surface Malignancies Unit, Colon and Rectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Oncology, Jehangir Hospital, Pune, Maharashtra, India. · Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Peritoneal Surface Malignancies Unit, Colon and Rectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: · Pubmed 29703622
  • Peritoneal Malignancy Program, National Cancer Institute, via Venezian, 1, 20133, Milan, Italy. · Peritoneal Malignancy Program, National Cancer Institute, via Venezian, 1, 20133, Milan, Italy. Electronic address: · Department of Medical Oncology, National Cancer Institute, via Venezian, 1, 20133,Milan, Italy. · Laboratory Medicine Unit, National Cancer Institute, via Venezian, 1, 20133,Milan, Italy. · Pubmed 29503128
2017
  • a Department of Surgery , University of Chicago , Chicago , IL , USA. · b Fondazione IRCCS Istituto Nazionale Tumori Milano , Milano , Italy. · c Department of Surgical Oncology , University of Maryland Medical Center , Baltimore , MD , USA. · Pubmed 28664790
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Colon-Rectal Cancer Surgery Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Pubmed 28100259
2016
  • Laboratory of Experimental Molecular Pathology, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · MOSE-DEA University of Trieste, Trieste, Italy. · Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Experimental Oncology 1, Centro di Riferimento Oncologico, CRO Aviano National Cancer Institute, Aviano, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Adult Mesenchymal Tumor Medical Oncology Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 27705913
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Biomarker Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Molecular Pathology Unit, Department of Laboratory Medicine, Ospedale Cà Granda Niguarda, Milan, Italy. · Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy. · Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 26810896
  • Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy. · European School of Peritoneal Surface Oncology (ESPSO), Centro Nacional de Oncología S.A, Bogotá, Colombia. · Pathology department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy. · Pubmed 26572754
2015
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Karyopharm Therapeutics Inc., Newton, MA, USA. · Pubmed 25948791
  • Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Pubmed 25777091
2013
  • Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Pubmed 23456386
2008
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 18726890
2016
  • MedStar Washington Hospital Center, Washington, DC; University of Chicago, Chicago, IL; University of Maryland School of Medicine, Baltimore, MD; Mesothelioma Applied Research Foundation, Alexandria, VA; and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Pubmed 27858561
2013
  • Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian, 1 20133 Milan, Italy. · Pubmed 23831335
2012
  • Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Pubmed 22302266
2011
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 21283990
2010
  • Department of Surgery, Istituto Nazionale per la Cura e lo Studio dei Tumori, Milan, Italy. · Pubmed 20832234
  • Experimental Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milano, Italy. · Pubmed 20692828
  • Department of Surgery National Cancer Institute, Milan, Italy. · Pubmed 20572597
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19856030
2009
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19368148
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19368141
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19082859
2008
  • Department of Experimental Oncology and Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 18593991
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 18396799
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 30 total) written by Marcello Deraco about Mesothelioma:

  • Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy. 2018
  • Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study. 2018
  • Current management strategies for peritoneal mesothelioma. 2017
  • Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism. 2017
  • Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. 2016
  • Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework. 2016
  • CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts. 2016
  • The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). 2016
  • Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. 2015
  • Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray. 2015
Show List of Full Article Records
Google Searches

Learn more about Marcello Deraco using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Cancer Institute Milan
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Cancer Institute Milan
2018
  • Peritoneal Surface Malignancies Unit, Colon and Rectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Surgery A, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Israel. · Peritoneal Surface Malignancies Unit, Colon and Rectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Oncology, Jehangir Hospital, Pune, Maharashtra, India. · Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Peritoneal Surface Malignancies Unit, Colon and Rectal Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: · Pubmed 29703622
  • Peritoneal Malignancy Program, National Cancer Institute, via Venezian, 1, 20133, Milan, Italy. · Peritoneal Malignancy Program, National Cancer Institute, via Venezian, 1, 20133, Milan, Italy. Electronic address: · Department of Medical Oncology, National Cancer Institute, via Venezian, 1, 20133,Milan, Italy. · Laboratory Medicine Unit, National Cancer Institute, via Venezian, 1, 20133,Milan, Italy. · Pubmed 29503128
2017
  • a Department of Surgery , University of Chicago , Chicago , IL , USA. · b Fondazione IRCCS Istituto Nazionale Tumori Milano , Milano , Italy. · c Department of Surgical Oncology , University of Maryland Medical Center , Baltimore , MD , USA. · Pubmed 28664790
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Colon-Rectal Cancer Surgery Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. · Pubmed 28100259
2016
  • Laboratory of Experimental Molecular Pathology, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · MOSE-DEA University of Trieste, Trieste, Italy. · Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Experimental Oncology 1, Centro di Riferimento Oncologico, CRO Aviano National Cancer Institute, Aviano, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Adult Mesenchymal Tumor Medical Oncology Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 27705913
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Biomarker Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Molecular Pathology Unit, Department of Laboratory Medicine, Ospedale Cà Granda Niguarda, Milan, Italy. · Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy. · Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 26810896
  • Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy. · European School of Peritoneal Surface Oncology (ESPSO), Centro Nacional de Oncología S.A, Bogotá, Colombia. · Pathology department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy. · Pubmed 26572754
2015
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Karyopharm Therapeutics Inc., Newton, MA, USA. · Pubmed 25948791
  • Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Pubmed 25777091
2013
  • Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Pubmed 23456386
2008
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 18726890
2016
  • MedStar Washington Hospital Center, Washington, DC; University of Chicago, Chicago, IL; University of Maryland School of Medicine, Baltimore, MD; Mesothelioma Applied Research Foundation, Alexandria, VA; and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Pubmed 27858561
2013
  • Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian, 1 20133 Milan, Italy. · Pubmed 23831335
2012
  • Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Pubmed 22302266
2011
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 21283990
2010
  • Department of Surgery, Istituto Nazionale per la Cura e lo Studio dei Tumori, Milan, Italy. · Pubmed 20832234
  • Experimental Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milano, Italy. · Pubmed 20692828
  • Department of Surgery National Cancer Institute, Milan, Italy. · Pubmed 20572597
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19856030
2009
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19368148
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19368141
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 19082859
2008
  • Department of Experimental Oncology and Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 18593991
  • Department of Surgery, National Cancer Institute, Milan, Italy. · Pubmed 18396799
8 Other Locations Show
Yearly article counts 22420233453
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.